Past Papers · SAQ
Vasoactive Pharmacology — Nitroprusside vs GTN
2025B Q09
Exam questionCompare and contrast the following pharmacology of sodium nitroprusside and glyceryl trinitrate; (a) mechanism of action (25% of marks) (b) pharmacodynamics and toxicity (75% of marks). Treatment of toxicity is NOT required.
CICMWrecks answer
Master answer
Master Compare
Compare candidate-facing canonical Pharmacopeia fields side by side. Isolated AI-draft proposals are never included.
| Field |
SODIUM NITROPRUSSIDE (SNiP)
Cardiovascular · Cardiovascular · Level 2
|
GLYCERYL TRINITRATE (GTN)
Cardiovascular · Cardiovascular · Level 2
|
|---|---|---|
| Mechanism of action | The nitroso group (−N = O−) in sodium nitroprusside reacts with sulphydryl groups (–SH) in vascular smooth muscle, forming nitric oxide and nitrosothiol derivatives. Both metab stimulate guanylate cyclase, ↑cGMP levels and produce generalized relaxation of vascular smooth muscle (both arterial and venular dilatation) |
MoA is same for inorganic nitrates although GTN must first combine with Thio containing compound to produce NO. NO activates guanylyl cyclase in smooth muscles which ↑cGMP leading to a ↓intracellular Ca and vasodilation. Venous > arterial dilation and the benefits in angina are believed to be related to decreased MVO2. |
| Physiological effects | Equal Arterial and venous dilation |
Venous > arterial dilation |
| Adverse Effects Toxicity | Main side effects are from excessive hypotension and include nausea, vomitting, abdominal pain, and postural hypotension. Abrupt withdrawal may lead to a rebound hypertension. Longer term there is significant risk of cyanide accumulation and associated toxicity and impaired oxidative phosphorylation. (See Special points below for further details) |
Tolerance develops rapidly due to depletion of sulphydryl (thiol) groups reqrd for metabolism of GTN to NO2. Breaks for patches (See Special points below for further details) |
Past papers
Exam appearances
| Exam | Exact exam wording | Candidate success |
|---|---|---|
| 2025B Q09 | Compare and contrast the following pharmacology of sodium nitroprusside and glyceryl trinitrate; (a) mechanism of action (25% of marks) (b) pharmacodynamics and toxicity (75% of marks). Treatment of toxicity is NOT required. | 21% |
| 2016B Q02 | Compare and contrast the mechanisms of action and toxicity of sodium nitroprusside and glyceryl trinitrate (GTN). | 55% |
| 2008B Q20 | Compare and contrast the pharmacology of sodium nitroprusside and glyceryl trinitrate. | — |
| 2008A Q15 | Compare and contrast the pharmacology of sodium nitroprusside and glyceryl trinitrate for the treatment of acute hypertension | 66% |